⌘K

Home/Filings/4/0001493152-22-025450

4//SEC Filing

Linscott Walt Addison 4

Accession 0001493152-22-025450

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 9:00 AM ET

Size

4.6 KB

Accession

0001493152-22-025450

Insider Transaction Report

Form 4

Period: 2022-09-07

Indaptus Therapeutics, Inc.INDP

Linscott Walt Addison

Chief Operating Officer

Transactions

Purchase
Common stock
2022-09-07$2.62/sh+150$393→ 150 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001648585

Filing Metadata

Form type: 4
Filed: Sep 8, 8:00 PM ET
Accepted: Sep 9, 9:00 AM ET
Size: 4.6 KB

View on SEC.gov